Scynexis (SCYX) Net Equity Issued and Repurchased (2016 - 2025)
Scynexis' (SCYX) quarterly Net Equity Issued and Repurchased came in at $1000.0 in Q4 2025, up 125.0% on a QoQ basis from -$4000.0 in Q3 2023.
Scynexis (SCYX) Net Equity Issued and Repurchased (2016 - 2025) Analysis & Trends
Scynexis (SCYX) has 9 years of Net Equity Issued and Repurchased data on file, last reported at $1000.0 in Q4 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $1000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3000.0 (changed N/A YoY) and the FY2025 annual result came in at $5000.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased rose to $1000.0 in Q4 2025, from -$4000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $30.5 million in Q4 2021 to a low of -$4000.0 in Q3 2023.
- A 4-year average of $4.2 million and a median of $216968.5 in 2021 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased slumped 44.34% — and 2023, when it tumbled 104.0%.
- Tracing SCYX's Net Equity Issued and Repurchased over 4 years: stood at $30.5 million in 2021, then sank by 99.67% to $100000.0 in 2022, then plunged by 104.0% to -$4000.0 in 2023, then soared by 125.0% to $1000.0 in 2025.
- The last three Net Equity Issued and Repurchased figures came in at $1000.0 (Q4 2025), -$4000.0 (Q3 2023), and $4000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Scynexis | 61.90 Mn | -52.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 2.16 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 30.53 Mn |
| Dec 31, 2021 | 30.53 Mn |
| Sep 30, 2021 | 333,937.00 |
| Sep 30, 2021 | 333,937.00 |
| Jun 30, 2021 | 800,000.00 |
| Jun 30, 2021 | 800,000.00 |
| Dec 31, 2020 | 85.85 Mn |
| Dec 31, 2020 | 85.85 Mn |
| Sep 30, 2020 | 600,000.00 |
| Sep 30, 2020 | 600,000.00 |